Hematology
14.9K views | +8 today
Hematology
Diagnosis, Therapy, Follow-up
Your new post is loading...
Your new post is loading...
Rescooped by Gilbert C FAURE from from Flow Cytometry to Cytomics
July 26, 2012 3:42 PM
Scoop.it!

In leukemia, discovery of Mer protein in cancer cells' nuclei offers ...

In leukemia, discovery of Mer protein in cancer cells' nuclei offers ... | Hematology | Scoop.it
From www.coloradocancerblogs.org - March 13, 2012 12:27 PM
A University of Colorado Cancer Center study, recently published in the journal PLoS ONE, found another home for Mer – inside cancer cells' nuclei – and perhaps another role for this protein that can point the way to novel, ...
Read more
more...
No comment yet.
Sign up to comment
Rescooped by Gilbert C FAURE from from Flow Cytometry to Cytomics
July 26, 2012 3:40 PM
Scoop.it!

Global Hematology Instruments and Reagents Market to Reach US$5.6 Billion by ... - Virtual-Strategy Magazine

Global Hematology Instruments and Reagents Market to Reach US$5.6 Billion by ... - Virtual-Strategy Magazine | Hematology | Scoop.it
From www.virtual-strategy.com - April 20, 2012 2:10 PM
Global Hematology Instruments and Reagents Market to Reach US$5.6 Billion by ...Virtual-Strategy Magazine...
Read more
more...
No comment yet.
Sign up to comment
Rescooped by Gilbert C FAURE from from Flow Cytometry to Cytomics
July 26, 2012 3:39 PM
Scoop.it!

New Microscope Imaged Flow of Individual Blood Cells

New Microscope Imaged Flow of Individual Blood Cells | Hematology | Scoop.it
From scicasts.com - May 21, 2012 3:47 PM
The team's device relies on a technique called spectrally encoded confocal microscopy. (a) A single line within a blood vessel is imaged with multiple colors of light that encode lateral positions. (b) A single cell crossing the spectral line ...
Read more
more...
No comment yet.
Sign up to comment
Rescooped by Gilbert C FAURE from from Flow Cytometry to Cytomics
July 26, 2012 3:37 PM
Scoop.it!

Oncology News - Clinical significance of minimal residual disease detected by multidimensional flow cytometry: Serial monitoring after allogeneic stem cell transplantation for acute leukemia |4114489

From www.mdlinx.com - June 22, 2012 11:49 AM
Oncology Medical Article: Clinical significance of minimal residual disease detected by multidimensional flow cytometry: Serial monitoring after allogeneic stem cell transplantation for acute leukemia (Clinical significance of minimal residual disease...
Read more
more...
No comment yet.
Sign up to comment
Rescooped by Gilbert C FAURE from from Flow Cytometry to Cytomics
July 26, 2012 3:36 PM
Scoop.it!

leukemia

From www.nature.com - July 7, 2012 3:24 AM

The novel tribody [(CD20)2xCD16] efficiently triggers effector cell-mediated lysis of malignant B cells

Read more
more...
No comment yet.
Sign up to comment
Rescooped by Gilbert C FAURE from from Flow Cytometry to Cytomics
July 26, 2012 3:35 PM
Scoop.it!

Hundreds of random mutations in leukemia related to aging, not cancer | Newsroom | Washington University in St. Louis

Hundreds of random mutations in leukemia related to aging, not cancer | Newsroom | Washington University in St. Louis | Hematology | Scoop.it
From news.wustl.edu - July 21, 2012 3:18 PM
Cancer cells noted to have hundreds of random mutations related to aging, but only two related to cancer http://t.co/QFpHUkM3 #cancer #aging...
Read more
more...
No comment yet.
Sign up to comment
Rescooped by Gilbert C FAURE from Immunology and Biotherapies
July 26, 2012 3:31 PM
Scoop.it!

Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia - Full Text View - ClinicalTrials.gov

From clinicaltrials.gov - July 20, 2012 11:11 AM
Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute My...
Read more
more...
No comment yet.
Sign up to comment
Rescooped by Gilbert C FAURE from Immunology and Biotherapies
July 26, 2012 3:30 PM
Scoop.it!

Cytomedix Announces Collaboration With Duke University on Phase ...

From cancerkick.com - July 18, 2012 8:44 AM
Cytomedix, Inc. (CMXI) (the “Company”), a regenerative therapies company commercializing and developing innovative platelet and adult stem cell technologies, announces the initiation of a Phase I clinical study with ...
Read more
more...
No comment yet.
Sign up to comment
Rescooped by Gilbert C FAURE from from Flow Cytometry to Cytomics
July 26, 2012 3:41 PM
Scoop.it!

Sysmex America Launches Sysmex WAM Select™ Middleware

Sysmex America Launches Sysmex WAM Select™ Middleware | Hematology | Scoop.it
From www.reuters.com - March 22, 2012 4:35 PM
Sysmex America Launches Sysmex WAM Select™ Middleware Software enhances operations efficiency for small to medium-sized clinical laboratories (Delphic Haematology middleware solution - Sysmex WAM Select launched in the US http://t.co/O6zIqh1W...)...
Read more
more...
No comment yet.
Sign up to comment
Rescooped by Gilbert C FAURE from from Flow Cytometry to Cytomics
July 26, 2012 3:39 PM
Scoop.it!

Clinical significance of minimal residual disease d... [Leuk Res. 2012] - PubMed - NCBI

From www.ncbi.nlm.nih.gov - May 7, 2012 3:32 AM
PubMed comprises more than 21 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
Read more
more...
No comment yet.
Sign up to comment
Rescooped by Gilbert C FAURE from from Flow Cytometry to Cytomics
July 26, 2012 3:37 PM
Scoop.it!

Flow Cytometry: The Standard Diagnostic Test for PNH

From www.pnhsource.eu - June 21, 2012 2:43 AM
Flow cytometry is the standard test for PNH diagnosis.
Read more
more...
No comment yet.
Sign up to comment
Rescooped by Gilbert C FAURE from from Flow Cytometry to Cytomics
July 26, 2012 3:36 PM
Scoop.it!

EHA 17: Impressive results with a bispecific antibody for ALL - Prof Max Topp - University of Wuerzberg, Germany

EHA 17: Impressive results with a bispecific antibody for ALL - Prof Max Topp - University of Wuerzberg, Germany | Hematology | Scoop.it
From ecancer.org - July 3, 2012 5:47 AM
Prof Max Topp - University of Wuerzberg, Germany (ecancer.tv editor choice: Impressive results with a bispecific antibody for ALL http://t.co/Y7bb8055 #cancer #EHA17...)...
Read more
more...
No comment yet.
Sign up to comment
Rescooped by Gilbert C FAURE from from Flow Cytometry to Cytomics
July 26, 2012 3:35 PM
Scoop.it!

Absolute lymphocyte counts refine minimal residual disease-based risk stratification in childhood acute lymphoblastic leukemia - Rabin - 2011 - Pediatric Blood & Cancer - Wiley Online Library

Absolute lymphocyte counts refine minimal residual disease-based risk stratification in childhood acute lymphoblastic leukemia - Rabin - 2011 - Pediatric Blood & Cancer - Wiley Online Library | Hematology | Scoop.it
From onlinelibrary.wiley.com - July 12, 2012 4:13 PM
Absolute lymphocyte counts refine minimal residual disease-based risk stratification in #pediatric ALL.
Read more
more...
No comment yet.
Sign up to comment
Rescooped by Gilbert C FAURE from Immunology and Biotherapies
July 26, 2012 3:32 PM
Scoop.it!

Genetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell Non-Hodgkin Lymphoma - Full Text View - Clinica...

From clinicaltrials.gov - July 19, 2012 3:35 PM
T-cell therapy with Transplant in Treating High-Risk, Intermediate-Grade, B-cell Non-Hodgkin Lymphoma - CITY OF HOPE http://t.co/6sbVbYD5...
Read more
more...
No comment yet.
Sign up to comment
Rescooped by Gilbert C FAURE from Immunology and Biotherapies
July 26, 2012 3:31 PM
Scoop.it!

Biotest’s Antibody-drug Conjugate BT-062 In Multiple Myeloma Combination Therapy

Biotest’s Antibody-drug Conjugate BT-062 In Multiple Myeloma Combination Therapy | Hematology | Scoop.it
From trialx.com - July 20, 2012 9:57 AM
Biotest’s Antibody-drug Conjugate BT-062 In Multiple Myeloma Combination Therapy (#clinicaltrials Biotest’s Antibody-drug Conjugate BT-062 In Multiple Myeloma Combination Therapy: BT-062, an ant...)...
Read more
more...
No comment yet.
Sign up to comment
Rescooped by Gilbert C FAURE from Immunology and Biotherapies
July 26, 2012 3:30 PM
Scoop.it!

Elotuzumab, CS1 Directed Antibody Therapy For Multiple Myeloma: Clinical Trial Results

Elotuzumab, CS1 Directed Antibody Therapy For Multiple Myeloma: Clinical Trial Results | Hematology | Scoop.it
From trialx.com - July 18, 2012 8:28 AM
Elotuzumab, CS1 Directed Antibody Therapy For Multiple Myeloma: Clinical Trial Results (#clinicaltrials Elotuzumab, CS1 Directed Antibody Therapy For Multiple Myeloma: Clinical Trial Results: Monoclon...)...
Read more
more...
No comment yet.
Sign up to comment
About Follow us Resources Terms Mobile Features
Facebook
X
LinkedIn